Granzyme B May Act as an Effector Molecule to Control the Inflammatory Process in COPD

Area of Science:

• Immunology
• Pulmonology
• Cell Biology

Background:

• Chronic obstructive pulmonary disease (COPD) pathogenesis is complex, with only a subset of smokers developing severe disease.
• The role of regulatory T (Treg) cells and autoimmunity in COPD is gaining recognition.
• Previous studies indicate fewer Treg cells in smokers with COPD compared to smokers without COPD or nonsmokers.

Purpose of the Study:

• To investigate the role of Treg cells and granzyme B (GzmB) in COPD pathogenesis and progression.
• To explore GzmB as a potential functional marker for Treg cells in COPD.
• To understand the relationship between GzmB levels and lung function decline in smokers.

Main Methods:

• Analysis of Treg cell counts in lung tissue and bronchoalveolar lavage fluid from smokers with and without COPD.
• Immunohistochemical staining for GzmB in lung tissue samples from patients with centrilobular emphysema.
• Correlation analysis between Treg cell counts, GzmB expression, and FEV₁% (forced expiratory volume in 1 second).

Main Results:

• Smokers with COPD exhibit fewer Treg cells than smokers without COPD or nonsmokers.
• A positive correlation exists between Treg cell count and FEV₁%, suggesting Treg cells' role in COPD progression.
• GzmB+ cell levels in lung tissue correlate with FEV₁%, comparable to Treg cell counts, indicating GzmB as a functional marker for Treg cells.

Conclusions:

• GzmB content in lung tissue may dictate COPD progression by regulating inflammatory processes.
• GzmB serves as a potential functional marker for immunosuppressive Treg cells in COPD.
• Augmenting GzmB-producing immunosuppressive cells early in COPD could prevent or delay disease progression.